BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24910454)

  • 1. CD44(+) CD324(-) expression and prognosis in gastric cancer patients.
    Cao L; Hu X; Zhang J; Liang P; Zhang Y
    J Surg Oncol; 2014 Nov; 110(6):727-33. PubMed ID: 24910454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
    Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
    Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
    Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
    Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 variant 6 and lymphatic invasion: importance to lymph node metastasis in gastric cancer.
    Kurozumi K; Nishida T; Nakao K; Nakahara M; Tsujimoto M
    World J Surg; 1998 Aug; 22(8):853-7; discussion 857-8. PubMed ID: 9673558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
    Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
    Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
    Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
    Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
    Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early gastric cancer: univariate and multivariate analysis for survival.
    Tuech JJ; Cervi C; Pessaux P; Villapadierna F; Bergamaschi R; Ronceray J; Arnaud JP
    Hepatogastroenterology; 1999; 46(30):3276-80. PubMed ID: 10626201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
    Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
    Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant prognostic factors in patients with node-negative gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.